A bill to amend the Federal Food, Drug, and Cosmetic Act to establish new prohibited acts relating to dietary supplements.
Impact
If enacted, SB4215 would significantly change the regulatory landscape for dietary supplements. It establishes new definitions and exclusions related to the introduction of dietary products into the market. This would grant the FDA greater authority to enforce regulations and potentially initiate seizures of products that do not meet set standards. Additionally, the incorporation of debarment provisions indicates a shift toward holding manufacturers and distributors accountable for safety violations, which could have profound implications for industry practices and consumer safety.
Summary
SB4215 is a legislative proposal aimed at amending the Federal Food, Drug, and Cosmetic Act to introduce new prohibited acts relating to the regulation of dietary supplements. The bill seeks to enforce stricter compliance measures by establishing specific conditions under which dietary supplements may be marketed and distributed in interstate commerce. By defining the criteria for what constitutes a dietary supplement and detailing offenses related to non-compliance, the bill aims to enhance consumer protection and safety standards in the dietary supplement industry.
Contention
The bill may face contention primarily from dietary supplement manufacturers, who might argue that the new regulations could impose undue burdens on their operations. Critics could express concerns about overreach by federal authorities into a largely self-regulated industry, fearing that excessive regulation might stifle innovation and limit consumer choice. Furthermore, discussions surrounding the balance between consumer protection and industry freedom are likely to emerge, as stakeholders weigh the necessity of stringent regulations against the potential fallout for businesses navigating these new laws.
A bill to amend the Internal Revenue Code of 1986 to include certain over-the-counter dietary supplement products and foods for special dietary uses as qualified medical expenses.
To amend the Federal Food, Drug, and Cosmetic Act to encourage the development of vaccines to prevent, treat, or mitigate opioid, cocaine, methamphetamine, or alcohol use disorder, to establish an x-prize for the development of such a vaccine, and for other purposes.